News Alert: FDA authorizes booster shots for 12-to-15-year-olds as students return to the classroom amid omicron variant surge
| The Food and Drug Administration's decision would clear additional shots of the Pfizer-BioNTech vaccine for younger adolescents and would also make boosters available for children 5 to 11 whose immune systems are compromised. The Centers for Disease Control and Prevention and its advisers will review the FDA action, with a recommendation expected midweek. |
 |
| | | | News Alert | Jan. 3, 9:50 a.m. EST | | | | | The Food and Drug Administration's decision would clear additional shots of the Pfizer-BioNTech vaccine for younger adolescents and would also make boosters available for children 5 to 11 whose immune systems are compromised. The Centers for Disease Control and Prevention and its advisers will review the FDA action, with a recommendation expected midweek. | | | | | |
| |
